All News #Library
Biotech
Cervomed Updates Neflamapimod, Joins Biomarkers Panel
07 Apr 2026 //
GLOBENEWSWIRE
CervoMed To Present At AD/PD 2026 Conference
12 Mar 2026 //
GLOBENEWSWIRE
CervoMed To Participate In Upcoming Investor Conferences
05 Mar 2026 //
GLOBENEWSWIRE
Cervomed Shows Neflamapimod Improves Neuroinflammation In (DLB)
02 Dec 2025 //
GLOBENEWSWIRE
Cervomed Appoints David Quigley To Strengthen Board
28 Oct 2025 //
GLOBENEWSWIRE
CervoMed Showcases Neflamapimod Benefits for Lewy Body Dementia
17 Sep 2025 //
GLOBENEWSWIRE
CervoMed: RewinD-LB Trial Shows Neflamapimod Slows Dementia
28 Jul 2025 //
GLOBENEWSWIRE
CervoMed to Share Phase 2b RewinD-LB Study Data at AAIC 2025
24 Jul 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support